<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">Cardiovascular disease</z:e> is currently one of the biggest causes of morbidity and mortality facing humanity </plain></SENT>
<SENT sid="1" pm="."><plain>Such a paradigm shift of disease pattern over the last century has only worsened due to the alarming global prevalence of <z:hpo ids='HP_0001513'>obesity</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>In recent years there is increasing focus on <z:mp ids='MP_0001845'>inflammation</z:mp> as one of the key players in the patho-<z:mp ids='MP_0001532'>physiology</z:mp> of these disorders </plain></SENT>
<SENT sid="3" pm="."><plain>In addition to these overt risk factors new research is unraveling the significance of a constellation of early <z:mp ids='MP_0005266'>metabolic abnormalities</z:mp> that include <z:mp ids='MP_0005456'>weight gain</z:mp>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, <z:e sem="disease" ids="C1696708" disease_type="Disease or Syndrome" abbrv="">prehypertension</z:e> and a specific pattern of <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>There exists a complex interrelationship of these various <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> and their effect on cardiovascular system </plain></SENT>
<SENT sid="5" pm="."><plain>Simplified explanation can be that <z:mp ids='MP_0001845'>inflammation</z:mp> increases <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, which in turn leads to <z:hpo ids='HP_0001513'>obesity</z:hpo> while perpetuating <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:mp ids='MP_0002842'>high blood pressure</z:mp>, prothrombotic state and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>While <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> have direct adverse effects on cardiac muscle, these <z:mp ids='MP_0005266'>metabolic abnormalities</z:mp> as a whole cause causes cardiovascular complications; warranting a multi pronged therapeutic and preventive approach for the 'Cardiovascular <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">Metabolic Syndrome</z:e>' as an entity </plain></SENT>
</text></document>